Oxygenta Pharma Avoids SEBI 'Large Corporate' Status Due to Low Borrowings

OTHER
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Oxygenta Pharma Avoids SEBI 'Large Corporate' Status Due to Low Borrowings
Overview

Oxygenta Pharmaceutical Ltd has confirmed it does not qualify as a 'Large Corporate' under SEBI rules. Its outstanding long-term borrowings of ₹107.31 crore are well below the ₹1,000 crore threshold, exempting the company from SEBI's enhanced disclosure requirements for FY 2026-2027.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Oxygenta Pharmaceutical Ltd, a player in India's pharmaceutical sector, has confirmed it does not meet the definition of a 'Large Corporate' under Securities and Exchange Board of India (SEBI) regulations. The company reported outstanding long-term borrowings of ₹107.31 crore as of March 31, 2026. This amount is well below the ₹1,000 crore threshold set by SEBI for this classification. Consequently, Oxygenta is exempt from the enhanced disclosure requirements applicable to large corporates for FY 2026-2027, as per SEBI's October 19, 2023 circular.

SEBI's 'Large Corporate' framework is designed to boost transparency and accountability for companies with substantial debt. By staying under the ₹1,000 crore limit, Oxygenta Pharmaceutical avoids a more extensive compliance regime, thereby reducing its administrative and reporting workload.

Market watchers will likely observe Oxygenta Pharmaceutical's future borrowing strategies and growth plans. Any future updates from SEBI concerning the 'Large Corporate' definition or the company's overall financial performance will also be of interest.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.